DXd, has been approved in the US for the treatment of adult patients with unresectable or metastatic hormone receptor HR-positive, HER2-negative breast cancer who have received prior endocrine-based ...

The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with ...

Two new studies have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials against breast cancer.

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...

Although Pfizer is not among the drugmakers suing the government to block negotiations, it has said the program will hinder drug R&D and innovation.

The approval is based on findings from the phase 3, multicenter, open-label, randomized TROPION-Breast01 trial.

And, in fact, this study showed that the additional palbociclib to this kind of treatment was able to significantly prolong PFS from the start of the maintenance treatment with a benefit in terms of ...

The overall average breast cancer incidence rate in the U.S. was 131.8 per 100,000 and the overall average breast cancer mortality rate was 19.3 per 100,000. Among women in the U.S., breast cancer ...

Genetic testing is recommended for those with personal and family histories of several types of cancer — including pancreatic ...